Top Midday Gainers

MT Newswires Live

Yesterday

Eightco Holdings (OCTO) said Monday it priced a private placement for 171.2 million shares at $1.46 each for gross proceeds of about $250 million. The company also said it received a $20 million investment from BitMine Immersion Technologies (BMNR).

Shares soared multifold as intraday trading volume surged to over 181.6 million from a daily average of about 1.13 million.

Rapport Therapeutics (RAPP) said Monday its phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.

Shares more than doubled as intraday trading volume soared to over 12.2 million from a daily average of roughly 179,000.

Beyond Air (XAIR) said Monday that the US Food and Drug Administration has granted orphan drug designation for its lead investigational therapy BA-101 to treat glioblastoma, which is an aggressive type of brain cancer.

Shares surged over 59% as intraday trading volume soared to more than 157.2 million from a daily average of about 278,000.

Price: 63.08, Change: +61.63, Percent Change: +4250.34

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2566636969"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566636969\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566636969?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-09 01:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566636969","market":"hk","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/OCTO\">Eightco Holdings</a> (OCTO) said Monday it priced a private placement for 171.2 million shares at $1.46 each for gross proceeds of about $250 million. The company also said it received a $20 million investment from <a href=\"https://laohu8.com/S/BMNR\">BitMine Immersion</a> Technologies (BMNR).</p><p>Shares soared multifold as intraday trading volume surged to over 181.6 million from a daily average of about 1.13 million.</p><p>Rapport <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (RAPP) said Monday its phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.</p><p>Shares more than doubled as intraday trading volume soared to over 12.2 million from a daily average of roughly 179,000.</p><p><a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a> (XAIR) said Monday that the US Food and Drug Administration has granted orphan drug designation for its lead investigational therapy BA-101 to treat glioblastoma, which is an aggressive type of brain cancer.</p><p>Shares surged over 59% as intraday trading volume soared to more than 157.2 million from a daily average of about 278,000.</p><p>Price: 63.08, Change: +61.63, Percent Change: +4250.34</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-09 01:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/OCTO\">Eightco Holdings</a> (OCTO) said Monday it priced a private placement for 171.2 million shares at $1.46 each for gross proceeds of about $250 million. The company also said it received a $20 million investment from <a href=\"https://laohu8.com/S/BMNR\">BitMine Immersion</a> Technologies (BMNR).</p><p>Shares soared multifold as intraday trading volume surged to over 181.6 million from a daily average of about 1.13 million.</p><p>Rapport <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (RAPP) said Monday its phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.</p><p>Shares more than doubled as intraday trading volume soared to over 12.2 million from a daily average of roughly 179,000.</p><p><a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a> (XAIR) said Monday that the US Food and Drug Administration has granted orphan drug designation for its lead investigational therapy BA-101 to treat glioblastoma, which is an aggressive type of brain cancer.</p><p>Shares surged over 59% as intraday trading volume soared to more than 157.2 million from a daily average of about 278,000.</p><p>Price: 63.08, Change: +61.63, Percent Change: +4250.34</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2566636969","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566636969","pubTimestamp":1757353631,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Eightco Holdings  said Monday it priced a private placement for 171.2 million shares at $1.46 each for gross proceeds of about $250 million. The company also said it received a $20 million investment from BitMine Immersion Technologies .Shares soared multifold as intraday trading volume surged to over 181.6 million from a daily average of about 1.13 million.Rapport Therapeutics  said Monday its phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.Shares more than doubled as intraday trading volume soared to over 12.2 million from a daily average of roughly 179,000.Beyond Air  said Monday that the US Food and Drug Administration has granted orphan drug designation for its lead investigational therapy BA-101 to treat glioblastoma, which is an aggressive type of brain cancer.Shares surged over 59% as intraday trading volume soared to more than 157.2 million from a daily average of about 278,000.Price: 63.08, Change: +61.63, Perce","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","XAIR":"BEYOND AIR INC","RAPP":"Rapport Therapeutics, Inc.","BMNR":"BitMine Immersion Technologies Inc.","BK4007":"制药","OCTO":"Eightco Holdings","BK4136":"纸材料包装","BK4023":"应用软件","BK4147":"半导体设备"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMNR":1,"OCTO":0.9,"RAPP":0.9,"XAIR":0.9},"content_text":"Eightco Holdings (OCTO) said Monday it priced a private placement for 171.2 million shares at $1.46 each for gross proceeds of about $250 million. The company also said it received a $20 million investment from BitMine Immersion Technologies (BMNR).Shares soared multifold as intraday trading volume surged to over 181.6 million from a daily average of about 1.13 million.Rapport Therapeutics (RAPP) said Monday its phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures met its primary endpoint.Shares more than doubled as intraday trading volume soared to over 12.2 million from a daily average of roughly 179,000.Beyond Air (XAIR) said Monday that the US Food and Drug Administration has granted orphan drug designation for its lead investigational therapy BA-101 to treat glioblastoma, which is an aggressive type of brain cancer.Shares surged over 59% as intraday trading volume soared to more than 157.2 million from a daily average of about 278,000.Price: 63.08, Change: +61.63, Percent Change: +4250.34","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}